AAAAAA

   
Results: 1-8 |
Results: 8
Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients
Authors: Cuffini, AM Tullio, V Giacchino, F Mandras, N Scalas, D Belardi, P Merlino, C Carlone, NA
Citation: Am. Cuffini et al., Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients, AM J KIDNEY, 37(6), 2001, pp. 1253-1259
Improved phagocyte response by co-amoxiclav in renal transplant recipients
Authors: Cuffini, AM Tullio, V Giacchino, F Bonino, A Mandras, N Bianchi, N Roana, J Scalas, D Bonello, F Carlone, NA
Citation: Am. Cuffini et al., Improved phagocyte response by co-amoxiclav in renal transplant recipients, TRANSPLANT, 71(4), 2001, pp. 575-577
Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin), on macrophage functions against Klebsiella pneumoniae: an in vitro comparison with pefloxacin
Authors: Tullio, V Cuffini, AM Bonino, A Palarchio, AI Roana, J Mandras, N Rossi, V Carlone, NA
Citation: V. Tullio et al., Influence of a new fluoroquinolone, AF3013 (the active metabolite of prulifloxacin), on macrophage functions against Klebsiella pneumoniae: an in vitro comparison with pefloxacin, J ANTIMICRO, 46(2), 2000, pp. 241-247
Antidermatophytic action of new 1-naphthylmethyl and benzo[b]thiophen-7-ylmethyl hydrazones related to inhibitors of squalene epoxidase
Authors: Auzzas, L Palomba, H Boatto, G Manconi, P Pau, A Becciu, A Cerri, R Tullio, V Roana, J Carlone, N
Citation: L. Auzzas et al., Antidermatophytic action of new 1-naphthylmethyl and benzo[b]thiophen-7-ylmethyl hydrazones related to inhibitors of squalene epoxidase, PHARMAZIE, 55(7), 2000, pp. 483-489
Cellular uptake and intraphagocytic activity of the new fluoroquinolone AF3013 against Klebsiella pneumoniae
Authors: Tullio, V Cuffini, AM Bonino, A Palarchio, I Rossi, V Carlone, NA
Citation: V. Tullio et al., Cellular uptake and intraphagocytic activity of the new fluoroquinolone AF3013 against Klebsiella pneumoniae, DRUG EXP CL, 25(1), 1999, pp. 1-11
Co-amoxiclav affects cytokine production by human polymorphonuclear cells
Authors: Reato, G Cuffini, AM Tullio, V Palarchio, AI Bonino, A Foa, R Carlone, NA
Citation: G. Reato et al., Co-amoxiclav affects cytokine production by human polymorphonuclear cells, J ANTIMICRO, 43(5), 1999, pp. 715-718
CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellularregulated kinase activation, leading to cytotoxic function of human NK cells
Authors: Palmieri, G Tullio, V Zingoni, A Piccoli, M Frati, L Lopez-Botet, M Santoni, A
Citation: G. Palmieri et al., CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellularregulated kinase activation, leading to cytotoxic function of human NK cells, J IMMUNOL, 162(12), 1999, pp. 7181-7188
Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae
Authors: Cuffini, AM Tullio, V Palarchio, AI Bonino, A Paizis, G Carlone, NA
Citation: Am. Cuffini et al., Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae, DRUG EXP CL, 24(4), 1998, pp. 173-184
Risultati: 1-8 |